Vicarious Surgical

About

Vicarious Surgical was a surgical robotics company that developed a miniaturized surgical robot designed to fit through a single 1.5-centimeter incision for minimally invasive procedures. The company went public through a SPAC merger in 2021 at a $1.1 billion valuation but burned through approximately $300 million in funding before shutting down operations in 2025, marking one of the most expensive failures in the surgical robotics sector.

Key Products